The Feasibility of 3D Therapy Thrive for Inpatients With Opioid Use Disorder
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Opioid Use Disorder
- Sponsor
- 3D Therapy, LLC
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Retention in Treatment
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This study aims to evaluate feasibility of a virtual reality software device and measure the effects of the intervention on OUD patient mood, tension and cravings, as well as the effect of treatment on patient retention to their inpatient detox protocol.
Detailed Description
The primary objective of this study is to evaluate the feasibility and preliminary effectiveness of a novel virtual reality (VR) based intervention; 3D Therapy Thrive (3DTT). Inpatient detoxification can improve outcomes for individuals with opioid use disorder (OUD), however patients often leave treatment early due to mood, tension, and cravings associated with opioid withdrawal. Subjects were recruited from a community inpatient detoxification program and received up to two sessions of 3DTT. The patients completed surveys to assess their mood, distress, cravings, and overall satisfaction with the experience. Retention was measured by protocol completion as reported by clinic staff, independent of the study. A group of patients with OUD consecutively admitted to the program comprised a comparison treatment-as-usual (TAU) group.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Retention in Treatment
Time Frame: At departure from facility, through study completion, an average of 10 days
Medical record indicating whether patient completed detox protocol (i.e., completed, left against medical advice, administratively discharged, or moved to higher level of care)
Feasibility and Tolerability of 3DTT
Time Frame: Immediately after each treatment
Feasibility and tolerability of 3DTT was measured by the Side Effects Questionnaire.
Secondary Outcomes
- Mood(Before and after each treatment, approximately every other day for up to 5 days)
- Anxiety(Before and after each treatment, approximately every other day for up to 5 days)
- Cravings(Before and after each treatment, approximately every other day for up to 5 days)